Article
Non-p.V600E BRAF Mutations Are Common Using a More Sensitive and Broad Detection Tool
18 Sept 2015
Abstract excerpt
OBJECTIVES: To assess the performance of a next-generation sequencing (NGS) platform for the clinical detection of BRAF mutations. METHODS: In this retrospective quality assessment of an NGS assay, we analyzed BRAF mutations within parts of exons 11 and 15 in 835 neoplastic tissues submitted to our molecular diagnostics laboratory. RESULTS: The NGS assays detected a BRAF mutation in 5.9% of lung adenocarcinomas,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
